Xiao-I Corporation shares plunged 29.6% Friday, capping a volatile week that saw short interest decline 30% even as borrowing costs remain elevated at 72%. The stock trades at $0.76 after a 516% surge over the past month.
AIXI closed at $0.76 on April 24, down 29.6% on the day. The stock fell 12.7% for the week but remains up 516% over the past month. The extreme volatility reflects a micro-cap name with limited liquidity and wild swings in sentiment.
Short interest stands at 2.54 million shares, representing 19.2% of the free float as of April 23. That marks a 30% decline over the past week — down from 2.81 million shares on April 17. The pullback follows an even steeper retreat from the April 9 peak of 5.29 million shares, when short interest briefly spiked above 100% utilization.
Cost to borrow sits at 72.4%, up from 56.1% a day earlier but down sharply from the April 10 peak of 769.5%. The current level is still 482% higher than a month ago, when CTB hovered around 12%. Utilization reached 89.7% on April 23, just below the 52-week high of 100% last visited April 3–9. The stock hit maximum utilization for six consecutive sessions earlier this month as shares became nearly impossible to borrow.
The pattern suggests a short squeeze that has partially unwound. Short sellers who chased the stock higher in early April have covered aggressively. Those who remain face borrowing costs that, while off the peak, still reflect a crowded and risky trade.
AIXI ranks in the 1st percentile for short score, meaning it exhibits higher short-related risk than 99% of stocks. The ORTEX short score of 80.5 has held steady near that level throughout April. Days to cover ranks in the 81st percentile — a relatively high reading that amplifies squeeze potential when combined with elevated utilization.
Dividend score sits at the 32nd percentile. Sector score is at the 30th percentile. Enterprise value is $53.3 million as of year-end 2025, though that figure is now four months old.
Founder Hui Yuan holds 1.09 million shares, or 10.2% of the company, unchanged from April 2025. UBS Asset Management added 279,000 shares in Q4 2025, bringing its stake to 2.6%. SmartHarvest Portfolios increased by 35,871 shares in Q1 2026 to 122,229 shares (1.1%). Citadel Advisors added 89,051 shares in Q4 to reach 108,850 shares (1.0%).
Jane Street, XTX Markets, and Two Sigma Securities each initiated positions in Q4 2025, acquiring 50,291, 42,314, and 38,968 shares respectively. The mix of market makers and hedge funds reflects the stock's trading-oriented appeal rather than long-term conviction.
The company reported earnings on April 24, the same day as Friday's sharp selloff. Prior earnings dates fell on January 9, 2026, December 31, 2025, and October 9, 2025. No price reaction data is available for these events. The next earnings event is scheduled for September 25, 2026.
The September earnings date is five months out. Nearer-term, watch whether short interest stabilizes or continues to decline. A further drop toward 10% of float would signal capitulation. Conversely, any rekindling of retail interest could reignite the squeeze dynamic if utilization climbs back toward 100%.
Borrowing costs remain a live wire. CTB above 70% keeps pressure on existing shorts and deters new entrants. If the stock continues to fall and CTB normalizes below 20%, the setup would shift decidedly bearish.
See the live data behind this article on ORTEX.
Open AIXI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
